Purchase of Medicines -065

PhilippinesTenders notice for Purchase of Medicines -065. The reference ID of the tender is 124298672 and it is closing on 19 Aug 2025.

100% Secure Payments

Tender Details

  • Country: Philippines
  • Summary: Purchase of Medicines -065
  • PHT Ref No: 124298672
  • Deadline: 19 Aug 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 864460.00
  • Notice Type: Tender
  • Document Ref. No.: TAYSAN2025-065
  • Purchaser's Detail :
  • Purchaser : MUNICIPALITY OF TAYSAN, BATANGAS
    margie celemen africa
    BAC Secretary
    Poblacion West Taysan Batangas
    Taysan
    Batangas
    Philippines 4228
    63-043-7842235
    Email :taysanbac2020@gmail.com

  • Description :
  • Tender are invited for PURCHASE OF MEDICINES -065
    Procurement Mode : Public Bidding
    Classification : Goods
    Category : Drugs and Medicines
    Contract Duration : 30 Day/s
    Budget for the Contract : PHP 864,460.00
    Area of Delivery : Batangas
    Description : PURCHASE OF MEDICINES
    Trade Agreement : Implementing Rules and Regulations
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
PhilippinesTenders Features

PhilippinesTenders Features

Fresh and verified Tenders from Philippines. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Philippines in your email inbox.

  Chat with us